Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,953 across all filing types
Latest filing 2026-04-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2026年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the fiscal year 2026. It details the estimated amounts, types of transactions, related parties, and includes explanations about the nature and necessity of these transactions. It also includes independent directors' opinions and board meeting resolutions related to these transactions. The document is not a full financial report, audit report, or earnings release, but rather a regulatory announcement about anticipated related party dealings. This fits the category of a Regulatory Filing (RNS), as it is a general regulatory announcement about related party transactions and does not contain comprehensive financial statements or detailed financial analysis.
2026-04-08 Chinese
2025年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2025 年度财务决算报告" which translates to "2025 Annual Financial Settlement Report". It contains detailed financial data including balance sheet items, profit and loss statement, cash flow statement, and key financial ratios for the full fiscal year 2025. The data includes year-end balances and comparisons with the previous year 2024, indicating a comprehensive annual financial report. The document is 3634 characters long, which is relatively short but contains substantive financial data and analysis, not just an announcement or a certification. There is no indication that this is a mere announcement of a report or a certification letter. The content matches the definition of an Annual Report (10-K) as it covers company activity and full financial performance for the year. Therefore, the appropriate classification is Annual Report (10-K). FY 2025
2026-04-08 Chinese
2025年度总经理工作报告
Management Reports Classification · 95% confidence The document is titled as the "2025年度总经理工作报告" (2025 Annual General Manager Work Report) of 阳普医疗科技股份有限公司. It contains detailed management commentary on the company's financial performance, operational review, strategic initiatives, and plans for the next year. It includes financial data such as revenue, net profit, assets, and operational highlights, as well as management's discussion of business strategy, market conditions, innovation, governance, and future outlook. This type of content aligns with a Management Report (MDA), which provides management's detailed explanation of financial results, business trends, and outlook. The document is not a full annual report (10-K), nor is it an earnings release or regulatory filing. It is a comprehensive management narrative report for the fiscal year 2025, consistent with the Management Reports category.
2026-04-08 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 90% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the year 2025 by 阳普医疗科技股份有限公司. It contains specific financial data related to fund balances, transactions, and related parties. However, the document is only 2100 characters long, which is quite short for a full financial report like an Annual Report (10-K) or Interim Report (IR). It does not appear to be an announcement or a certification but rather a specific financial summary related to related party transactions and fund usage. This type of document is typically a regulatory disclosure or compliance filing about related party transactions and fund occupation, which does not fit neatly into the main financial report categories. Given the short length and the nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2026-04-08 Chinese
董事会关于独立董事独立性情况的专项意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 阳普医疗科技股份有限公司 regarding the independence of its independent directors for the year 2025. It references compliance with regulatory guidelines and confirms the independent status of the directors. The content is a specific board/management announcement about director independence, not a full report or financial statement. The document length is short (542 characters), and it is clearly a board statement rather than a report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG).
2026-04-08 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司2025 年年度报告全文" which translates to "Improve Medical Instruments Co., Ltd. 2025 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2025, management discussion and analysis, governance, and financial statements. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial data, management commentary, and detailed business descriptions. There is no indication that this is merely an announcement or a certification. Therefore, this document is the official Annual Report for the fiscal year 2025. FY 2025
2026-04-08 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.